American Bio Medica Co. (OTCMKTS:ABMC) passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $0.06 and traded as low as $0.04. American Bio Medica shares last traded at $0.04, with a volume of 12,317 shares trading hands.
The firm’s 50-day moving average is $0.04 and its 200-day moving average is $0.06. The company has a market cap of $1.77 million, a PE ratio of -1.31 and a beta of -2.06.
American Bio Medica (OTCMKTS:ABMC) last announced its quarterly earnings results on Wednesday, August 18th. The company reported ($0.01) earnings per share (EPS) for the quarter. The company had revenue of $0.53 million for the quarter.
American Bio Medica Corp. is a biotechnology company. It engages in the manufacture and sale of immunoassay tests, primarily for the immediate detection of certain drugs in urine and oral fluids. The firm’s products include Rapid Drug Screen, Rapid ONE, RDS InCup, Rapid TOX, Rapid TOX Cup II, and OralStat.
Further Reading: Growth and Income Funds
Receive News & Ratings for American Bio Medica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Bio Medica and related companies with MarketBeat.com's FREE daily email newsletter.